Can a Biomarker Predict Which Ischemic Stroke Patients Benefit From Anticoagulants or Antiplatelet Agents?
From the AAN Annual Meeting: Can a biomarker predict which ischemic stroke patients benefit from anticoagulants or antiplatelet agents? In a video interview, Neurology Today’s
Editor-in-Chief Steven P. Ringel, MD, and Associate Editor Robert Holloway, MD, discuss the key clinical takeaways from the latest analysis of data from the Antiphospholipid
Antibodies and Stroke Study and the Warfarin-Aspirin Recurrent Stroke Study.
May 16, 2013, Volume 13, Issue 10;